2 news items
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
OVID
14 May 24
ended March 31, 2024. "This is an exhilarating period for Ovid. Our innovative programs are progressing through clinical
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
ADXN
BIVI
EVO
24 Apr 24
shares is at $1.8 billion. The company's, Q4 earnings came out today.
Innovative Eyewear
- Prev
- 1
- Next